ROME Therapeutics Competitors and Similar CompaniesClear all
ROME Therapeutics's competitors and similar companies include Memgen, Mersana Therapeutics, Seagen and Vyriad.
 ROME Therapeutics Rome Therapeutics is a company that develops therapies to cure cancer and autoimmune diseases. |  Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms. |  Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. | |||
Founding Date | Founding Date 2020 | Founding Date 2004 | Founding Date 2005 | Founding Date 1998 | Founding Date 2016 |
Type | Type Private | Type Private | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Houston, US HQ | Locations Cambridge, US HQ | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations Rochester, US HQ |
Employees | Employees 405% increase | Employees 7 | Employees 11033% increase | Employees 3,25622% increase | Employees 49 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2024) | Revenue (est.) $2b (FY, 2022) | Revenue (est.) N/A |
Net income | Net income N/A | Net income N/A | Net income ($69.2m) (FY, 2024) | Net income ($610.3m) (FY, 2022) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 50m (about 6 years ago) | Latest funding round $ 865k (over 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 24.4m (over 6 years ago) |
Total funding raised | Total funding raised $ 50m | Total funding raised $ 8.5m | Total funding raised $ 219.5m | Total funding raised $ 164m | Total funding raised $ 24.4m |
For sources of this data, please see the company profile
View Company Profiles
Mersana Therapeutics
HQ
Cambridge, US
Employees
110↑ 33% increase
Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.
View companySeagen
HQ
Bothell, US
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View company
Vyriad
HQ
Rochester, US
Employees
49
Vyriad is a company that develops a biopharmaceutical platform designed to cure cancer.
View company